JPS6468370A - Isoxazole beta carboline derivative, manufacture and central nervous system remedy - Google Patents

Isoxazole beta carboline derivative, manufacture and central nervous system remedy

Info

Publication number
JPS6468370A
JPS6468370A JP63210869A JP21086988A JPS6468370A JP S6468370 A JPS6468370 A JP S6468370A JP 63210869 A JP63210869 A JP 63210869A JP 21086988 A JP21086988 A JP 21086988A JP S6468370 A JPS6468370 A JP S6468370A
Authority
JP
Japan
Prior art keywords
isoxazole
manufacture
nervous system
central nervous
carboline derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP63210869A
Other languages
English (en)
Other versions
JP2690329B2 (ja
Inventor
Fuuto Andoreasu
Raatsu Deiitaa
Roode Rarufu
Shiyumiihien Rarufu
Zaideruman Deiitaa
Hansu Shiyunaidaa Heruberuto
Nooman Suchiibunsu Debuitsudo
Bondo Hansen Yoon
Engerusutofuto Moogensu
Orusen Pureeben
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK449887A external-priority patent/DK449887D0/da
Priority claimed from DE19873730667 external-priority patent/DE3730667A1/de
Application filed by Schering AG filed Critical Schering AG
Publication of JPS6468370A publication Critical patent/JPS6468370A/ja
Application granted granted Critical
Publication of JP2690329B2 publication Critical patent/JP2690329B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP63210869A 1987-08-28 1988-08-26 イソオキサゾール−β−カルボリン−誘導体、その製法及びこれを含有する中枢神経作用剤 Expired - Lifetime JP2690329B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK449887A DK449887D0 (da) 1987-08-28 1987-08-28 Beta-carbolinderivater, deres fremstilling og anvendelse
DE19873730667 DE3730667A1 (de) 1987-09-09 1987-09-09 Neue ss-carboline
DE3730667.7 1987-09-09
DE4498/87 1987-09-09

Publications (2)

Publication Number Publication Date
JPS6468370A true JPS6468370A (en) 1989-03-14
JP2690329B2 JP2690329B2 (ja) 1997-12-10

Family

ID=25859709

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63210869A Expired - Lifetime JP2690329B2 (ja) 1987-08-28 1988-08-26 イソオキサゾール−β−カルボリン−誘導体、その製法及びこれを含有する中枢神経作用剤

Country Status (15)

Country Link
US (1) US4933345A (ja)
EP (1) EP0305322B1 (ja)
JP (1) JP2690329B2 (ja)
AU (1) AU619203B2 (ja)
CA (1) CA1324382C (ja)
DE (1) DE3888428D1 (ja)
ES (1) ES2061716T3 (ja)
FI (1) FI88160C (ja)
HU (1) HU203101B (ja)
IE (1) IE65712B1 (ja)
IL (1) IL87563A (ja)
NO (1) NO167287C (ja)
NZ (1) NZ225959A (ja)
PT (1) PT88351B (ja)
RU (1) RU1836369C (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4118741A1 (de) * 1991-06-05 1992-12-10 Schering Ag Neue hetaryloxy-(beta)-carboline, deren herstellung und verwendung in arzneimitteln
US5543519A (en) * 1991-06-15 1996-08-06 Schering Aktiengesellschaft 3-aryl or 3-hetaryl-β-carbolines, their production and use in pharmaceutical agents
DE4120109A1 (de) * 1991-06-15 1992-12-17 Schering Ag 3-aryl- oder 3-hetaryl-(beta)-carboline, deren herstellung und verwendung in arzneimitteln
DE4130933A1 (de) * 1991-09-13 1993-03-18 Schering Ag Neue (beta)-carbolinderivate, deren herstellung und verwendung in arzneimitteln
JP3108483B2 (ja) * 1991-09-30 2000-11-13 日清製粉株式会社 インドール誘導体およびこれを有効成分とする抗潰瘍薬
DE4330175A1 (de) * 1993-08-31 1995-03-02 Schering Ag Alkoxy-substituierte beta-Carboline
US8765735B2 (en) * 2009-05-18 2014-07-01 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US8927551B2 (en) * 2009-05-18 2015-01-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US9149465B2 (en) * 2009-05-18 2015-10-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
FR2953837B1 (fr) * 2009-12-10 2012-03-09 Sanofi Aventis Derives 9h-pyridino[3,4-b]indole disubstitues, leur preparation et leur utilisation therapeutique
FR2953838B1 (fr) * 2009-12-10 2012-02-24 Sanofi Aventis Derives de 9h-beta-carboline (ou 9h-pyridino[3,4-b]indole) trisubstitues, leur preparation et leur utilisation therapeutique
US10947253B2 (en) 2019-08-05 2021-03-16 Ankh Life Sciences Limited Fused polycyclic dimers
US12129265B2 (en) 2020-07-21 2024-10-29 Ankh Life Sciences Limited Therapeutic agents and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57123180A (en) * 1980-12-17 1982-07-31 Schering Ag 3-substituted beta-carboline, manufacture and psychotropic drug containing same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3240511A1 (de) * 1982-10-29 1984-05-03 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von ss-carbolinderivaten
DE3240513A1 (de) * 1982-10-29 1984-05-03 Schering AG, 1000 Berlin und 4709 Bergkamen Indolderivate, verfahren zu ihrer herstellung und deren verwendung zur weiterverarbeitung
DE3240514A1 (de) * 1982-10-29 1984-05-03 Schering AG, 1000 Berlin und 4709 Bergkamen Ss-carboline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3322895A1 (de) * 1983-06-23 1985-01-03 Schering AG, 1000 Berlin und 4709 Bergkamen Neue ss-carboline, verfahren zur ihrer herstellung und ihre verwendung als arzneimittel (s)
DK240084D0 (da) * 1984-05-15 1984-05-15 Ferrosan As New beta-carboline-3-oxadiazolyl derivatives
DE3535927A1 (de) * 1985-10-04 1987-04-09 Schering Ag 3-vinyl- und 3-ethinyl-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel
DE3608089A1 (de) * 1986-03-08 1987-09-10 Schering Ag Heteroaryl-oxy-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57123180A (en) * 1980-12-17 1982-07-31 Schering Ag 3-substituted beta-carboline, manufacture and psychotropic drug containing same

Also Published As

Publication number Publication date
FI88160C (fi) 1993-04-13
IE882600L (en) 1989-02-28
AU619203B2 (en) 1992-01-23
FI883963A7 (fi) 1989-03-01
AU2150088A (en) 1989-03-02
IE65712B1 (en) 1995-11-15
CA1324382C (en) 1993-11-16
FI883963A0 (fi) 1988-08-26
JP2690329B2 (ja) 1997-12-10
RU1836369C (ru) 1993-08-23
EP0305322A3 (en) 1990-04-04
NO883833D0 (no) 1988-08-26
EP0305322A2 (de) 1989-03-01
EP0305322B1 (de) 1994-03-16
HUT48244A (en) 1989-05-29
US4933345A (en) 1990-06-12
IL87563A0 (en) 1989-01-31
HU203101B (en) 1991-05-28
PT88351B (pt) 1995-03-31
IL87563A (en) 1993-08-18
NO167287B (no) 1991-07-15
NO167287C (no) 1991-10-23
PT88351A (pt) 1989-06-30
DE3888428D1 (de) 1994-04-28
ES2061716T3 (es) 1994-12-16
NZ225959A (en) 1991-02-26
FI88160B (fi) 1992-12-31
NO883833L (no) 1989-03-01

Similar Documents

Publication Publication Date Title
GB2207355B (en) Therapeutic rings
JPS6422857A (en) Azolylmethyl-cyclopropyl derivative
PL270238A1 (en) Method for manufacturing avermectin b
ZA881835B (en) Avermectin derivatives
JPS6468378A (en) Novel avermectin derivative, its production and use
JPS6434950A (en) N-aminobutyl-n-phenylarylamide derivative
DK170889A (da) Anvendelse af a1(iii)- eller fe(iii)-chelater til bekaempelse af bloeddyr
EP0290915A3 (en) Flavone-3-carboxylic-acid compounds, and process, intermediates for their preparation and medicines containing these compounds
DE3888428D1 (de) Isoxazol-Beta-carbolin-Derivate.
JPS6468360A (en) Dihydropyridazinone derivative, manufacture and medicine
EP0295037A3 (en) Phenol derivatives, their production and use
GB8821121D0 (en) Ring mechanism
JPS6471871A (en) Biarylalkylimidazole derivative
JPS57181063A (en) Nitrogen-containing pentacyclic derivative, manufacture and medicine
JPS6466188A (en) Rifamycin derivative
JPS6426562A (en) Hydroxyethylazolyl derivative
JPS6468348A (en) Amino-2-hydroxypropyloxyiminoheterocycle beta insulator
GB8820701D0 (en) Central heating system
JPS6426569A (en) 1-phenoxy-3-triazolyl-1-hexene derivative
GB8724672D0 (en) Ring binder mechanisms
EP0285805A3 (en) New heptaene antibiotic, v-28-3m
JPS6426561A (en) Azolylmethyl-cyclopropylcarbinol derivative
EP0251115A3 (en) Method for the production of beta-halovinyl- and beta,bemethod for the production of beta-halovinyl- and beta,beta-dihaloethylarylketones ta-dihaloethylarylketones
JPS6445379A (en) Thiapentaneamide derivative
GB8700100D0 (en) Mid-water support